Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
about
Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: A comprehensive reviewDiacylglycerol kinase alpha regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytesMatrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisFas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammationOpposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.Immunotherapy of human cancers using gene modified T lymphocytes.The many roles of FAS receptor signaling in the immune systemTransplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.Targeting Fas in osteoresorptive disorders.Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.Fas ligand and the fate of antitumour cytotoxic T lymphocytes.Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED.Enzyme-instructed self-assembly: a multistep process for potential cancer therapyFas death receptor signalling: roles of Bid and XIAP.Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency.Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer.Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologicallyMesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosisNot so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signalingSalmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic TumorsOsteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.Platelets induce apoptosis via membrane-bound FasL.CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions.Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.Fas ligand triggers pulmonary silicosisA vision of cell death: Fas ligand and immune privilege 10 years later.Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complexMitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Role of TNF superfamily ligands in innate immunity.Life in the Fas lane: differential outcomes of Fas signaling.A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation.Cell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2.Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.
P2860
Q23917334-0F4B6794-9C3E-407E-ABB9-C1D86F3BE584Q28248440-E9F2B954-F405-48CA-9173-0B75EA29F3FBQ28344462-13E90F52-6E9F-4970-BD57-F6697FF61B3BQ33530092-0CC115EE-BD87-4D9F-AAAA-F9BF88A94AF2Q33607280-3F0133E8-4F56-42BD-8E3D-D2D24390A0A0Q33867607-02DAC075-F420-4798-9372-E190EE9F262AQ34188383-A2C121BE-B163-444A-A601-3DCD101105ECQ34205697-8DC30DBB-EB44-4B92-9066-C88C0475FA2BQ34418727-E8BE1889-1E34-44D8-ACBE-26971845C6A3Q34561691-CE57D1AF-7473-4562-B15B-E87E7D644989Q34577828-003B1A0E-8326-46D2-BA6A-16CBACDBA256Q34579773-BF3F64BC-786E-4636-BACA-E6CA19839FBDQ34592338-AD0691C0-1360-4547-8A80-32D5F2B3FBE3Q34734386-CAED3F1E-0BBE-4CFB-BF56-6A285BAFAC00Q35620158-B0436649-AFC6-4743-8BE4-EB38212DF6C7Q35657414-73867F0F-EDAA-4129-8747-899C8EDB65CBQ35748142-4F109C56-F42A-4B12-BFA8-792222777E28Q35783456-2C45447C-FE27-4F53-AD8D-81A0DA999E09Q35928288-2D042C57-237D-4C87-BA2F-37FFC4D7E628Q35946990-78962585-C2B5-4691-9C07-06939C5CC4C1Q35956638-9BA77E9A-604A-4CFF-8BF0-16EE37963000Q36029858-3AB88417-B114-4B4E-8D82-31FD66A3460DQ36031608-D0FDC7AB-A967-457B-92EA-84FB4F743F5EQ36040583-4FD12907-73D8-4A1E-A876-E88EDED6A9C7Q36070471-64F0143F-3660-48B6-B2B9-6ADA65342298Q36291143-8B4217F6-8B23-46B8-A6EC-A12791A5E398Q36349972-A9552192-AAA6-4A6E-AC8C-116382F02ED8Q36369388-494163C2-A806-416B-A68B-4F997CC077E2Q36593770-07E215BA-0AE9-4AC9-B141-1BB2CA2C6334Q36911426-95E1E348-13F0-4EF7-8D9E-017AF156F70AQ37314479-974BF4B0-AFFA-48BC-9C0B-E0E699E4F8ABQ37404771-E209BB15-E3B2-487F-90F4-E6703999CEC4Q37646545-9925C592-D5FB-4AE2-8CAA-D636A6BA3650Q37895960-BF0937E8-7B38-46B3-B70D-6F22253CECA8Q38098432-B375955A-F677-4E2D-A152-1D2A76007BF2Q38361696-927ABE59-7DE7-4B63-8CCA-6F5C6F253443Q39013916-FF260B81-3F33-4EB9-8A01-222523A6F350Q39184214-D42363CA-375C-488D-B629-1123909D6259Q39251222-357830E5-296D-4A10-85E8-40089D45AFACQ39418860-53C4F0CE-CFE5-43C3-B31D-B32BA1AAAC07
P2860
Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Opposing effects of transmembr ...... ation and tumor cell survival.
@ast
Opposing effects of transmembr ...... ation and tumor cell survival.
@en
type
label
Opposing effects of transmembr ...... ation and tumor cell survival.
@ast
Opposing effects of transmembr ...... ation and tumor cell survival.
@en
prefLabel
Opposing effects of transmembr ...... ation and tumor cell survival.
@ast
Opposing effects of transmembr ...... ation and tumor cell survival.
@en
P2093
P2860
P356
P1476
Opposing effects of transmembr ...... ation and tumor cell survival.
@en
P2093
A M Hohlbaum
A Marshak-Rothstein
P2860
P304
P356
10.1084/JEM.191.7.1209
P407
P577
2000-04-01T00:00:00Z